Pahr Therapeutics

Pahr Therapeutics is a clinical stage business, is to create innovative ways to treat pulmonary arterial hypertension.
Founded by
Investors:
RA Capital Management, UTEC - The University of Tokyo Edge Capital Partners, AN Ventures
$
Seed
14000000
Clinical Trials
Health Care
Description:
Pahr Therapeutics is a clinical-stage business whose goal is to create innovative ways to treat pulmonary arterial hypertension.
Key Metrics:
Total Raised
14000000
Team Size
Location
Last Funding
July 28, 2025
Contacts:
Email
Linkedin
Facebook